Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Herman van Besien, Antonella Sassano, Jessica K. Altman & Leonidas C. Platanias. (2013) Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Leukemia & Lymphoma 54:12, pages 2601-2605.
Read now
Read now
Articles from other publishers (39)
Muhammad Jamal, Yufei Lei, Hengjing He, Xingruo Zeng, Hina Iqbal Bangash, Di Xiao, Liang Shao, Fuling Zhou & Quiping Zhang. (2023) CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis. Frontiers in Pharmacology 14.
Crossref
Crossref
Wei Liu, Paweł Stachura, Haifeng C. Xu, Nikkitha Umesh Ganesh, Fiona Cox, Ruifeng Wang, Karl S. Lang, Jay Gopalakrishnan, Dieter Häussinger, Bernhard Homey, Philipp A. Lang & Aleksandra A. Pandyra. (2020) Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Mariana Nunes, Miguel Henriques Abreu, Carla Bartosch & Sara Ricardo. (2020) Recycling the Purpose of Old Drugs to Treat Ovarian Cancer. International Journal of Molecular Sciences 21:20, pages 7768.
Crossref
Crossref
Piotr Mrowka & Eliza Glodkowska-Mrowka. (2020) PPARγ Agonists in Combination Cancer Therapies. Current Cancer Drug Targets 20:3, pages 197-215.
Crossref
Crossref
Zhihua JiaoHuaqing Cai, Yu LongOrit Katarina SirkaVeena PadmanabanAndrew J. EwaldPeter N. Devreotes. (2020) Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects. Proceedings of the National Academy of Sciences 117:8, pages 4158-4168.
Crossref
Crossref
Liang Zhao, Huien Zhan, Xinya Jiang, Yangqiu LiHui Zeng. (2019) The role of cholesterol metabolism in leukemia. Blood Science 1:1, pages 44-49.
Crossref
Crossref
Anna Fracassi, Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni & Marco Segatto. (2018) Statins and the Brain: More than Lipid Lowering Agents?. Current Neuropharmacology 17:1, pages 59-83.
Crossref
Crossref
J. Scott Lee, Andrew Roberts, Dennis Juarez, Thanh-Trang T. Vo, Shruti BhattLee-or HerzogSharmila MallyaRichard J. Bellin, Suresh K. AgarwalAhmed Hamed Salem, Tu XuJia JiaLingxiao LiJohn R. HannaMatthew S. DavidsAngela G. Fleischman, Susan O’BrienLloyd T. Lam, Joel D. Leverson, Anthony LetaiJonathan H. Schatz & David A. Fruman. (2018) Statins enhance efficacy of venetoclax in blood cancers. Science Translational Medicine 10:445.
Crossref
Crossref
Giridhar Mudduluru, Wolfgang Walther, Dennis Kobelt, Mathias Dahlmann, Christoph Treese, Yehuda G. Assaraf & Ulrike Stein. (2016) Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets. Drug Resistance Updates 26, pages 10-27.
Crossref
Crossref
Beth Binnington, Long Nguyen, Mustafa Kamani, Delowar Hossain, David L Marks, Monique Budani & Clifford A Lingwood. (2016) Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling. Glycobiology 26:2, pages 166-180.
Crossref
Crossref
Masako Yokoo, Yasushi Kubota, Keiichi Motoyama, Taishi Higashi, Masatoshi Taniyoshi, Hiroko Tokumaru, Rena Nishiyama, Yoko Tabe, Sakiko Mochinaga, Akemi Sato, Naoko Sueoka-Aragane, Eisaburo Sueoka, Hidetoshi Arima, Tetsumi Irie & Shinya Kimura. (2015) 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent. PLOS ONE 10:11, pages e0141946.
Crossref
Crossref
Aleksandra Pandyra, Peter J. Mullen, Manpreet Kalkat, Rosemary Yu, Janice T. Pong, Zhihua Li, Suzanne Trudel, Karl S. Lang, Mark D. Minden, Aaron D. Schimmer & Linda Z. Penn. (2014) Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop. Cancer Research 74:17, pages 4772-4782.
Crossref
Crossref
J W Clendening & L Z Penn. (2012) Targeting tumor cell metabolism with statins. Oncogene 31:48, pages 4967-4978.
Crossref
Crossref
Maja Osmak. (2012) Statins and cancer: Current and future prospects. Cancer Letters 324:1, pages 1-12.
Crossref
Crossref
Patrizia Gazzerro, Maria Chiara Proto, Giuseppina Gangemi, Anna Maria Malfitano, Elena Ciaglia, Simona Pisanti, Antonietta Santoro, Chiara Laezza & Maurizio Bifulco. (2012) Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer. Pharmacological Reviews 64:1, pages 102-146.
Crossref
Crossref
Antonio Rodriguez-Ariza, Chary Lopez-Pedrera, Enrique Aranda & Nuria Barbarroja. (2011) VEGF targeted therapy in acute myeloid leukemia. Critical Reviews in Oncology/Hematology 80:2, pages 241-256.
Crossref
Crossref
Peter Kubatka, Katarína Žihlavniková, Peter Solár, Karol Kajo, Vanda Valentová, Martin Péč, Bianka Bojková, Monika Kassayová, Nadežda Stollárová & Ivan Ahlers. (2011) Antitumor effects of atorvastatin in the chemoprevention of rat mammary carcinogenesis. Biologia 66:4, pages 727-734.
Crossref
Crossref
Anna Martirosyan, James W Clendening, Carolyn A Goard & Linda Z Penn. (2010) Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC Cancer 10:1.
Crossref
Crossref
Marek Jakobisiak & Jakub Golab. (2009) Statins can modulate effectiveness of antitumor therapeutic modalities. Medicinal Research Reviews 30:1, pages 102-135.
Crossref
Crossref
Susan D. P. W. M. de Jonge-Peeters, Karen van der Weide, Folkert Kuipers, Wim J. Sluiter, Elisabeth G. E. de Vries & Edo Vellenga. (2008) Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells. Annals of Hematology 88:6, pages 573-580.
Crossref
Crossref
Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Folkert Kuipers, Elisabeth G.E. de Vries & Edo Vellenga. (2009) Combining Simvastatin with the Farnesyltransferase Inhibitor Tipifarnib Results in an Enhanced Cytotoxic Effect in a Subset of Primary CD34+ Acute Myeloid Leukemia Samples. Clinical Cancer Research 15:9, pages 3076-3083.
Crossref
Crossref
Helena Gbelcová, Martin Leníček, Jaroslav Zelenka, Zdeněk Knejzlík, Gabriela Dvořáková, Marie Zadinová, Pavla Poučková, Michal Kudla, Peter Balaž, Tomáš Ruml & Libor Vítek. (2007) Differences in antitumor effects of various statins on human pancreatic cancer. International Journal of Cancer 122:6, pages 1214-1221.
Crossref
Crossref
W. Wei-Lynn Wong, James W. Clendening, Anna Martirosyan, Paul C. Boutros, Christina Bros, Fereshteh Khosravi, Igor Jurisica, A. Keith Stewart, P. Leif Bergsagel & Linda Z. Penn. (2007) Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Molecular Cancer Therapeutics 6:6, pages 1886-1897.
Crossref
Crossref
Susan D.P.W.M. de Jonge-Peeters, Folkert Kuipers, Elisabeth G.E. de Vries & Edo Vellenga. (2007) ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Critical Reviews in Oncology/Hematology 62:3, pages 214-226.
Crossref
Crossref
Antonella Sassano, Efstratios Katsoulidis, Giovanni Antico, Jessica K. Altman, Amanda J. Redig, Saverio Minucci, Martin S. Tallman & Leonidas C. Platanias. (2007) Suppressive Effects of Statins on Acute Promyelocytic Leukemia Cells. Cancer Research 67:9, pages 4524-4532.
Crossref
Crossref
Katja Hindler, Charles S. Cleeland, Edgardo Rivera & Charles D. Collard. (2006) The Role of Statins in Cancer Therapy. The Oncologist 11:3, pages 306-315.
Crossref
Crossref
HUANBIAO MO & CHARLES E. ELSON. 2006. Nutritional Oncology. Nutritional Oncology
629
644
.
Michael A. Morgan, Tarkan Sebil, Erdem Aydilek, Dietrich Peest, Arnold Ganser & Christoph W. M. Reuter. (2005) Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. British Journal of Haematology 130:6, pages 912-925.
Crossref
Crossref
Paola Cafforio, Franco Dammacco, Angela Gernone & Franco Silvestris. (2005) Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 26:5, pages 883-891.
Crossref
Crossref
M. Jalving, J. J. Koornstra, S. Jong, E. G. E. Vries & J. H. Kleibeuker. (2005) Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Alimentary Pharmacology and Therapeutics 21:4, pages 321-339.
Crossref
Crossref
Mark A. Moyad & Gregory S. Merrick. (2005) Statins and cholesterol lowering after a cancer diagnosis: Why not?. Urologic Oncology: Seminars and Original Investigations 23:1, pages 49-55.
Crossref
Crossref
Deborah E. BankerSasha J. MayerHenry Y. LiCheryl L. WillmanFrederick R. AppelbaumRichard A. Zager. (2004) Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104:6, pages 1816-1824.
Crossref
Crossref
Jianghong Wu, W. Wei-Lynn Wong, Fereshteh Khosravi, Mark D. Minden & Linda Z. Penn. (2004) Blocking the Raf/MEK/ERK Pathway Sensitizes Acute Myelogenous Leukemia Cells to Lovastatin-Induced Apoptosis. Cancer Research 64:18, pages 6461-6468.
Crossref
Crossref
Huanbiao Mo & Charles E. Elson. (2016) Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention. Experimental Biology and Medicine 229:7, pages 567-585.
Crossref
Crossref
Denise M. Boudreau, Jacqueline S. Gardner, Kathleen E. Malone, Susan R. Heckbert, David K. Blough & Janet R. Daling. (2004) The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women. Cancer 100:11, pages 2308-2316.
Crossref
Crossref
M A Morgan, A Ganser & C W M Reuter. (2003) Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia. Leukemia 17:8, pages 1482-1498.
Crossref
Crossref
D.L. Stirewalt, F.R. Appelbaum, C.L. Willman, R.A. Zager & D.E. Banker. (2003) Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression. Leukemia Research 27:2, pages 133-145.
Crossref
Crossref
W W-L Wong, J Dimitroulakos, MD Minden & LZ Penn. (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:4, pages 508-519.
Crossref
Crossref
Z Xia, MM Tan, W Wei-Lynn Wong, J Dimitroulakos, MD Minden & LZ Penn. (2001) Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia 15:9, pages 1398-1407.
Crossref
Crossref